Search

“We could not be more proud of this deserving group of the outstanding GSK students who have been recognized with fellowship support this academic year,” says GSK Dean Michael Overholtzer.

… Monday, October 25, 2021 Every year, the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences awards fellowships to students who show promise in their scientific endeavors at GSK. These fellowships, which are based on academic excellence, are made possible by generous philanthropic gifts

New MSK research shows how pancreatic cancer cells organize themselves to fuel tumor growth; finds an antibody-drug conjugate shows efficacy in rare pediatric sarcoma; develops an AI tool could accelerate identification of disease-causing genetic variants; and builds quantum nanosensors for cancer blood tests.

… Monday, April 27, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) reveals how pancreatic cancer cells organize themselves to fuel tumor growth; finds an antibody-drug conjugate shows efficacy in rare pediatric sarcoma; develops an AI tool could accelerate identification of disease-causing

See how the MSK Kids Class of 2020 celebrated their high school graduation.

… Thursday, July 2, 2020 Summary Though the setup was different, the MSK Kids Class of 2020 was still feted at a celebratory and empowering virtual commencement ceremony. The graduates at this year’s 14th Annual Convocation Ceremony know all about surmounting challenges and fostering resilience: They were

Here’s what to know about breast-feeding during chemotherapy and other treatments for cancer.

… Tuesday, August 2, 2016 Summary Many women in treatment for cancer struggle with whether to continue breast-feeding their baby. Whether it’s recommended depends on your particular situation. Resources and support are available to help you make an informed decision. Breast-feeding benefits babies and

A new finding provides insight into how breast cancer develops resistance to aromatase inhibitors.

… Thursday, September 3, 2020 Summary Many patients with estrogen-positive breast cancer develop resistance to drugs called aromatase inhibitors. MSK researchers have discovered that mutations in a gene called FOXA1 cause the cancer cells to grow and resist aromatase inhibitors in distinct ways. Most breast

Lung resection after initial nonoperative treatment for non-small cell lung cancer (NSCLC) was safe and led to significantly improved survival in select patients previously treated with nonoperative therapies, according to a study by Memorial Sloan Kettering Cancer Center (MSK) investigators.

… Monday, March 18, 2024 Lung resection after initial nonoperative treatment for non-small cell lung cancer (NSCLC) was safe and led to significantly improved survival in select patients previously treated with nonoperative therapies, according to a study by Memorial Sloan Kettering Cancer Center (MSK)

Memorial Sloan Kettering Cancer Center (MSK) is committed not only to providing exceptional cancer care but also to ensuring access to care for everyone who needs it. Unfortunately, some patients — often those whose insurance plan offers a very narrow provider network or those who are underinsured — have trouble shouldering the significant financial burden that can come with a cancer diagnosis. MSK has a special team in place to make sure these patients can still get the care they deserve.

… Monday, February 27, 2023 Memorial Sloan Kettering Cancer Center (MSK) is committed not only to providing exceptional cancer care but also to ensuring access to care for everyone who needs it. Unfortunately, some patients — often those whose insurance plan offers a very narrow provider network or those

El Memorial Sloan Kettering Cancer Center (MSK) se compromete no solo a brindar una atención excepcional para combatir el cáncer, sino también, a asegurar el acceso a la atención para todo aquel que lo necesite. Desafortunadamente, algunos pacientes (generalmente aquellos cuyo seguro ofrece una red de servicios muy reducida o aquellos que no están asegurados) se encuentran en problemas para afrontar la gran carga financiera que conlleva un diagnóstico de cáncer. MSK cuenta con un equipo especial que se asegura de que estos pacientes puedan recibir la atención que se merecen.

… Monday, February 27, 2023 El Memorial Sloan Kettering Cancer Center (MSK) se compromete no solo a brindar una atención excepcional para combatir el cáncer, sino también, a asegurar el acceso a la atención para todo aquel que lo necesite. Desafortunadamente, algunos pacientes (generalmente aquellos cuyo

A targeted approach being developed to treat certain cancers may also be effective for Alzheimer’s disease.

… Thursday, January 16, 2020 Summary Researchers find that a targeted approach being developed to treat certain cancers also appears to help rewire brain circuitry in Alzheimer’s disease. The body is presented with stressors throughout life. These stressors include genetic and environmental challenges

Results from a large phase III clinical trial unveiled at this year’s ASCO meeting identify an effective targeted therapy for a subset of people with pancreatic cancer.

… Sunday, June 2, 2019 Summary The results of a phase III trial presented on June 2 at the annual meeting of the American Society of Clinical Oncology (ASCO) show that a targeted drug called a PARP inhibitor benefits people with a BRCA mutation and pancreatic cancer that has spread. Pancreatic cancer that